Hombeck Torsten
- SEC CIK
- 0001983682
No open-market purchases or sales filed in the past year.
Current role at each company
- AKTX Akari Therapeutics PlcCFOas of Mar 24, 2025
- AWHL Aspira Women's Health Inc.Chief Financial Officeras of Jun 14, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Hombeck Torsten as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AWHL Aspira Women's Health Inc.
Chief Financial Officer2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 (view filing) | Sep 8 | 4 days | Hombeck TorstenChief Financial Officer | PPurchase | +2.25K | $4.30 | +$9.66K | +297.9%3.00K after | |
| Jul 24, 2023 (view filing) | Jul 24 | Same day | Hombeck TorstenChief Financial Officer | PPurchase | +754 | $3.98 | +$3.00K | New position754 after |